Among those 104 hub genes, we chose four significantly up-regulated genes, including CENPL, ISG20L2, MRPL3, and LSM4 as hub genes of interest due to the reason that they have rarely been studied in breast cancer and closely related to clinicopathological variables of BC patients. The gene discussed is MRPL3; the disease is breast carcinoma.